Compare Bandhan BSE Healthcare Index Fund vs UTI Healthcare Fund
Risk | Very High | Very High |
Rating | - | 4.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.02 | 2.26 |
NAV | ₹9.93 | ₹283.00 |
Fund Started | 21 Aug 2024 | 01 Aug 2005 |
Fund Size | ₹18.09 Cr | ₹1126.13 Cr |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | Exit load of 1% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
-
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.02
2.26
NAV
₹9.93
₹283.00
Fund Started
21 Aug 2024
01 Aug 2005
Fund Size
₹18.09 Cr
₹1126.13 Cr
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
Exit load of 1% if redeemed within 30 days.
1 Year | -1.44% | -1.09% |
3 Year | - | 24.09% |
5 Year | - | 15.29% |
1 Year
-1.44%
-1.09%
3 Year
-
24.09%
5 Year
-
15.29%
Equity | 100.00% | 98.75% |
Cash | 0.00% | 1.24% |
Equity
100.00%
98.75%
Cash
0.00%
1.24%
Top 10 Holdings |
|
|
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 14.10% |
Max Healthcare Institute Ltd. | 6.27% |
Cipla Ltd. | 6.22% |
Divi's Laboratories Ltd. | 6.02% |
Dr. Reddy's Laboratories Ltd. | 5.59% |
Apollo Hospitals Enterprise Ltd. | 5.38% |
Lupin Ltd. | 3.67% |
Fortis Healthcare Ltd. | 3.49% |
Laurus Labs Ltd. | 2.92% |
Torrent Pharmaceuticals Ltd. | 2.85% |
Sun Pharmaceutical Industries Ltd. | 9.76% |
Ajanta Pharma Ltd. | 6.48% |
Lupin Ltd. | 5.91% |
Glenmark Pharmaceuticals Ltd. | 4.06% |
Dr. Reddy's Laboratories Ltd. | 3.74% |
Gland Pharma Ltd. | 3.46% |
Apollo Hospitals Enterprise Ltd. | 3.45% |
Alkem Laboratories Ltd. | 3.43% |
Procter & Gamble Health Ltd. | 3.41% |
Cipla Ltd. | 3.40% |
Name | Nemish Sheth | Kamal Gada |
Start Date | 13 Feb 2025 | 02 May 2022 |
Name
Nemish Sheth
Kamal Gada
Start Date
13 Feb 2025
02 May 2022
Description | The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. |
Launch Date | 21 Aug 2024 | 01 Aug 2005 |
Description
The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
21 Aug 2024
01 Aug 2005